79 related articles for article (PubMed ID: 11848648)
1. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
[TBL] [Abstract][Full Text] [Related]
2. Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience.
Wildemeersch D; Andrade A; Goldstuck ND; Hasskamp T; Jackers G
Int J Womens Health; 2017; 9():49-58. PubMed ID: 28176932
[TBL] [Abstract][Full Text] [Related]
3. Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study.
Wildemeersch D; Jandi S; Pett A; Nolte K; Hasskamp T; Vrijens M
Int J Womens Health; 2014; 6():727-34. PubMed ID: 25125987
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and Effectiveness of Hysteroscopic Suture Fixation of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis.
Lv N; Guo J; Yuan Q; Shen S; Chen Q; Tong J
J Minim Invasive Gynecol; 2024 Jan; 31(1):57-63. PubMed ID: 37838016
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping.
Shi J; Gu Z; Wu Y; Li X; Zhang J; Zhang C; Yan H; Dai Y; Leng J
Arch Gynecol Obstet; 2024 Jul; 310(1):55-67. PubMed ID: 38836931
[TBL] [Abstract][Full Text] [Related]
6. Factors Predicting Removals of the Levonorgestrel-Releasing Intrauterine System in an Adolescent Cohort.
Baum A; Chan K; Sachedina A; Grover SR
J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):171-176. PubMed ID: 38128876
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
[TBL] [Abstract][Full Text] [Related]
8. Generalized sensory sensitivity is associated with comorbid pain symptoms: a replication study in women with dysmenorrhea.
Schrepf A; Hellman KM; Bohnert AM; Williams DA; Tu FF
Pain; 2023 Jan; 164(1):142-148. PubMed ID: 35543649
[TBL] [Abstract][Full Text] [Related]
9. Non-pharmacological that most effective to reduce of primary dysmenorrhea intensity in women childbearing age: a literature review.
Ilmiah WS; Abdullah I; Koesrini J
J Public Health Afr; 2023 Dec; 14(12):2349. PubMed ID: 38204814
[TBL] [Abstract][Full Text] [Related]
10. Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.
Bianchi P; Guo SW; Habiba M; Benagiano G
J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233703
[TBL] [Abstract][Full Text] [Related]
11. New intrauterine technologies for contraception and treatment in -nulliparous/adolescent and parous women.
Wildemeersch D
Facts Views Vis Obgyn; 2009; 1(3):223-32. PubMed ID: 25489467
[TBL] [Abstract][Full Text] [Related]
12. Contraceptive-related cerebral venous thrombosis with profuse vaginal bleed.
Narayanan TJ; Chowdary GV; Murthy JM
Neurocrit Care; 2005; 2(3):292-5. PubMed ID: 16159078
[TBL] [Abstract][Full Text] [Related]
13. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
14. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
15. Contraception with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2000 Dec; 5(4):234-40. PubMed ID: 11245550
[TBL] [Abstract][Full Text] [Related]
16. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
17. Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
Wildemeersch D; Andrade A
Gynecol Endocrinol; 2010 May; 26(5):383-9. PubMed ID: 20192899
[TBL] [Abstract][Full Text] [Related]
18. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E; Wildemeersch P
Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
